TGFB1 and neoplasm: They release immunosuppressive cytokines such as IL-10, IL-4, IL-13, IDO and TGF-β, reducing TNFα and INF-γ levels in effector CD4+ T cells, inhibiting APCs function, and downregulating tumor-specific cytotoxicity within the immune response.